Questions Posed To FDA Panels Should Be Agreed To By Sponsor-HIMA Says
This article was originally published in The Gray Sheet
Executive Summary
Questions submitted to FDA advisory panels for the review of premarket approval applications should be agreed upon by the sponsor of the device, the Health Industry Manufacturers Association contends.